Now on ScienceBlogs: Freethinker Sunday Sermonette: more religion and child abuse
musings on medicines from the Earth
Abel Pharmboy is the nom de plume of an academic researcher and educator who took his PhD in Pharmacology and Therapeutics and BS in Toxicology. He writes on natural product drugs and dietary supplements, academic career development, medical journalism and, occasionally, making and listening to music and, with the help of his colleague, Erleichda, wine appreciation.
"Why Terra Sigillata?" will tell you more about the origin of the blog name.
Please read the DISCLAIMER for details on the blog's intended audience, advertising and comment policy, and how not to use the information presented herein.
This site complies with the HONcode standard for trustworthy health information: Verify here.
October 30, 2006
Category: Blogging community
I've been delinquent in reading other blogs as of late, so I missed last week's arrival of Rick and Patty's new baby, Catherine, at Science, Shrimp and Grits. Rick is a great chemistry teacher in South Carolina who always has...
Posted by Abel Pharmboy at 6:39 AM • 0 Comments • 0 TrackBacks
October 27, 2006
Category: Blogging community
As Bora has posted, the NC Triangle area is about to be paid a visit by Chris Mooney, author of The Republican War on Science, Seed Magazine Washington correspondent, and ScienceBlogger at The Intersection. The book signing and lecture events...
Posted by Abel Pharmboy at 7:32 AM • 0 Comments • 0 TrackBacks
October 26, 2006
Category: Pharmacology
If you've been working in this field for any period of time, cocktail party discussions or talks with students invariably turn to nature's greatest trove of biologically-active compounds, those that act on the central nervous system (CNS) as stimulants, euphorics,...
Posted by Abel Pharmboy at 10:29 AM • 5 Comments • 0 TrackBacks
October 25, 2006
Category: Botanical/Herbal Medicines
Frequent commenter, anjou, just sent along a link to a MSNBC article by Robert Bazell entitled, "Ignoring the failures of alternative medicine." The article is subtitled, "The U.S. spends millions testing popular supplements. It's a futile effort." Bazell is chief...
Posted by Abel Pharmboy at 9:43 AM • 7 Comments • 0 TrackBacks
October 22, 2006
Category: Blog carnivals
After putting together last evening's carnival posts, I walked outside this morning to find the Q Opinion section of our local Sunday paper devoted to issues of blogging. Specifically, writer Eric Ferreri poses the question of whether bloggers should have...
Posted by Abel Pharmboy at 11:14 AM • 1 Comments • 0 TrackBacks
October 21, 2006
Category: Blog carnivals
Welcome to this week's edition of Tar Heel Tavern, a roundup of all that is good about blogging from the state of North Carolina. If I missed your submission or if it's Sunday morning and you think, "Dang, I forget...
Posted by Abel Pharmboy at 11:58 PM • 7 Comments • 0 TrackBacks
October 20, 2006
Category: The Friday Fermentable
This is kind of a homer version of The Friday Fermentable, but I think that it has enough international interest that I am putting it here and on the oft-neglected local blog, Bull City Bully Pulpit. Many themes will come...
Posted by Abel Pharmboy at 2:59 AM • 1 Comments • 0 TrackBacks
October 19, 2006
Category: Blogging community
Are you a North Carolina blogger of any sort? Have you ever lived in North Carolina? C'mon, I know many, many science folks who at one time did their training in the Old North State. Well, after hosting Tar Heel...
Posted by Abel Pharmboy at 10:11 PM • 1 Comments • 0 TrackBacks
Category: Botanical/Herbal Medicines
The real news in this story is how the lead researcher responsibly tempers the interpretation of his 15 October report in Clinical Cancer Research. From United Press International: Grape seeds may help attack colon tumors DENVER, Oct. 18 (UPI) --...
Posted by Abel Pharmboy at 7:51 AM • 3 Comments • 0 TrackBacks
October 18, 2006
Category: Cancer
SAHA, or suberoylanilide hydroxamic acid, was recently granted orphan drug approval by the US FDA for skin lesions resulting from cutaneous T-cell lymphoma. SAHA (vorinostat, Zolinza) will be marketed by Merck as they acquired in 2004 Aton Pharma, who had...
Posted by Abel Pharmboy at 1:19 PM • 0 Comments • 0 TrackBacks
